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Introduction {#sec0005}
============

Lymphatic filariasis (LF) is a disease of major public health significance, affecting people in the tropical areas of Africa, India, and South and Central America ([@bib0045]). It is caused by the filarial nematode *Wuchereria bancrofti* and is transmitted by a variety of genera of mosquitoes, including *Culex*, *Anopheles*, *Aedes*, and *Mansonia* ([@bib0010]). In Sub-Saharan Africa, the most important species of mosquito vector are *Anopheles* and *Culex* ([@bib0010]). Members of *the Anopheles gambiae* complex *Anopheles funestus* group and *Culex quinquefasciatus* have been identified as important filarial vectors in Tanzania ([@bib0085], [@bib0090]). Globally, it is estimated that 120 million people are infected with the parasite and approximately one billion are at risk of infection ([@bib0125]). Manifestations of the disease include chronic lymphoedema, elephantiasis involving the limbs and sometimes the genital area, chyluria, and attacks of acute adenolymphangitis ([@bib0015]). LF has been ranked as the leading cause of permanent disability in the world ([@bib0145]).

The World Health Organization (WHO) launched a global programme for the elimination of LF (GPELF) in 2000, with the goal of eliminating the disease globally by 2020 ([@bib0120]). The main strategy proposed to achieve LF elimination is the provision of repeated mass drug administration (MDA) with a combination of albendazole and either diethylcarbamazine or ivermectin to people living in endemic areas who are at risk of the disease ([@bib0020], [@bib0115]). These drug combinations are mainly microfilaricidal, aimed at reducing the transmission of the parasite. It is assumed that once the community has been treated long enough, levels of microfilariae will be reduced below the required threshold to sustain transmission ([@bib0075]). The period required to achieve this goal has been estimated at 4 to 6 years, which corresponds to the reproductive lifespan of the adult *W. bancrofti* worm ([@bib0080]).

It has been suggested that the interruption of transmission of this infection depends on the proportion of the population receiving antifilarial drugs every year. Furthermore, it was estimated that four to six annual rounds of MDA, with a minimum effective coverage of 60--70% of the target population, would be sufficient to interrupt transmission ([@bib0050]). However 5 years after the launch of the GPELF, it was concluded that more than four to six annual rounds of MDA may be required to interrupt transmission in many endemic areas ([@bib0110]).

Tanzania initiated the implementation of LF control with the launch of the Tanzanian National Lymphatic Filariasis Elimination Programme (NLFEP) in 1997 ([@bib0040]). The control strategy adopted by NLFEP was to apply annual MDA with a combination of ivermectin (150--200 mg/kg) and albendazole (400 mg) to all individuals aged 5 years and above living in selected endemic areas. In the year 2000, the Tanzanian NLFEP launched its first MDA campaign in Mafia District, in which 45 000 people were treated ([@bib0040]). The programme has expanded to cover more than 13 million people treated at least once, and the goal is to expand the programme to the entire at-risk population of around 39 million people ([@bib0030]).

Rufiji District in southeastern Tanzania started implementing MDA in 2002, with a baseline *W. bancrofti* circulating filarial antigen (CFA) prevalence ranging from 49% to 64% among the community members aged 5 years and above (Ministry of Health and Social Welfare (MoHSW) 2012, unpublished). From 2012, the MDA programme coincided with the universal distribution of long-lasting insecticide-treated nets (LLINs) by the malaria control programme in Tanzania, which aimed to cover 80% of the general population ([@bib0130]). The use of insecticide-treated nets (ITNs) for malaria control has shown a significant effect in lowering filarial rates ([@bib0065], [@bib0005], [@bib0060]).

Monitoring the effect of MDA on the transmission of lymphatic filariasis is crucial for measuring progress towards the elimination goal and also forms the basis for establishing treatment endpoints. Studies have indicated that the monitoring of circulating filarial antigen in young children who are born during the intervention period is a good indicator for assessing the impact of MDA in a community ([@bib0090]). In endemic regions, children are most susceptible to acquiring the infection because of their lack of immunity and high exposure to infective larvae; infections established in childhood may act as the reservoir for future disease later in life ([@bib0035]).

The use of new sensitive and highly specific diagnostic tools for the detection of CFA released by adult *W. bancrofti* parasites has shown that many children acquire the infection earlier than was previously thought and that often a considerable proportion of young children are CFA-positive. As reduced transmission will lead to reduced acquisition of infection, it has been suggested that young children be screened to assess the effectiveness of transmission interventions during the LF elimination programme. Children born after the initiation of MDA are of particular interest, as they provide an evaluation sample on the interruption of transmission. The current study monitored the impact of 12 rounds of MDA and the deployment of a universal LLIN coverage intervention on the prevalence of CFA in standard one school children in Rufiji.

Materials and methods {#sec0010}
=====================

Study site and population {#sec0015}
-------------------------

All study sites are located in Rufiji District in southeastern Tanzania (7°57′ S and 38°43′ E), which had a population of 217 274 people in 2012 (National Census 2012, National Bureau of Statistics, Tanzania). The district was purposively selected for this study due to its history of high LF transmission, with a baseline prevalence of *W. bancrofti* CFA reported at 49% before the start of control activities (MoHSW 2012, unpublished). The study sampled participants from the community (heads of households) and primary schools (standard one children) in the villages of Nyamisati, Mchukwi, Nyanjati, Bungu, and Nyambili in Rufiji. The villages were purposively selected to represent the diverse geographical features of the district. Nyamisati village lies in the coastal belt of the Indian Ocean, while Mchukwi, Nyanjati, Nyambili, and Bungu are inland villages. Each village has only one primary school and all standard one pupils in each school were recruited for the study.

A list of heads of households was obtained from the village officials in the enrolled villages. A simple random sampling technique was applied to obtain participants from each village. The selected participants were identified and recruited into the study. The enrolled heads of households were interviewed to gather information on MDA coverage and ITN use.

The NLFEP in Rufiji District was implemented in 2002. By 2014, the programme had administered 12 rounds of annual MDA, with an interruption in 2005 due to logistical issues. The current study was conducted from April to May in 2012 and was repeated at the same time in 2015, coinciding with the 9th and 12th rounds of MDA, respectively.

Detection of CFA and MDA participation {#sec0020}
--------------------------------------

On the survey dates, all standard one children were invited to participate in the blood screening using the class registers containing the names and sexes of the pupils. They were examined for CFA using immunochromatographic test cards (ICT) (BinaxNOW Filariasis; Inverness Medical Innovations Inc.); the manufacturer's instructions were followed. Prior to the field survey, two cards from the lot were tested in the laboratory using a positive control obtained from the National Institute for Medical Research, Tanzania. The results for both cards were positive.

In brief, a finger prick was conducted using a sterile disposable lancet after cleaning the finger with an alcohol swab. One hundred microlitres of finger-prick blood was collected using a sterile disposable capillary tube and applied to the test card. The results were read after exactly 10 min as positive, negative, or undetermined. Just after the blood test, the children were interviewed on their age and participation in the previous MDA rounds. To guide the pupils, the drugs used in the MDA were displayed to them and they were then asked if they had swallowed the drugs or not.

Assessment of community participation in MDA and utilization of ITNs {#sec0025}
--------------------------------------------------------------------

The treatment coverage was obtained using two different methods. The first method involved obtaining the official programme coverage for all administrative wards from the Rufiji District neglected tropical disease (NTD) coordination office. The second method involved interviews with the heads of households within the study villages to determine their participation in the MDA campaign and utilization of ITNs. Participants were asked whether they had participated in previous MDAs and whether household members slept under ITNs. The investigators asked if they could examine the respondents' bedrooms for the presence of ITNs in each household. Moreover, demographic information for the respondents and their reasons for not taking drugs during MDA rounds were also recorded.

Data analysis {#sec0030}
-------------

Data were entered into Excel and subsequently analyzed using IBM SPSS Statistics for Windows, version 20.0 (IBM Corp., Armonk, NY, USA). For the data analysis, respondents were categorized into three age groups: 15--29 years, 30--49 years, and ≥50 years. Educational status was categorized into four groups: those with no formal education, primary education, secondary education, and post-secondary education. The duration of stay in the village was categorized into four groups: since birth, less than 1 year, 1--5 years, and more than 5 years. The different categories were compared with the Chi-square test. *p*-Values of ≤0.05 were considered statistically significant.

Ethics {#sec0035}
------

This study was reviewed and approved by the Muhimbili University of Health and Allied Sciences Research Ethics Review Board, as well as the WHO Ethics Review Committee. Permission to conduct the study was obtained from the Executive Director of Rufiji District. The parents/guardians and community were informed of the purpose of the survey through the village meetings. Children were recruited at their respective schools and given consent forms (in Kiswahili) to give to their parents/guardians for consenting. Parents/guardians or school pupils who refused to participate in the surveys were excluded. Verbal consent to participate in the community component of the study was sought from the heads of households prior to the interviews.

Results {#sec0040}
=======

CFA prevalence and treatment coverage in pupils {#sec0045}
-----------------------------------------------

In 2012, 413 children aged between 6 and 9 years were screened for CFA in five selected primary schools. Of those screened, 236 (57.1%) were female and 177 (42.9%) were male. A total of 59 (14.3%) screened pupils were positive for *W. bancrofti* CFA ([Table 1](#tbl0005){ref-type="table"}). The prevalence of CFA increased significantly with increasing age of the pupils (Chi-square test of trends, *p* = 0.016; [Table 1](#tbl0005){ref-type="table"}). Just a third (33.7%) of the children screened in 2012 reported having swallowed the drugs in the 2011 MDA round. The prevalence of CFA was not significantly different among those who participated (12.2%) and those who did not participate (15.3%) in the 2011 MDA (Chi-square test, *p* = 0.4).Table 1CFA status among standard one school children aged 6 to 9 years in five different primary schools in Rufiji District.Table 1Name of school2012 Survey2015 SurveyNo. testedSex ratio[a](#tblfn0005){ref-type="table-fn"}Mean age (years)CFA positive (%)No. testedSex ratio[a](#tblfn0005){ref-type="table-fn"}Mean age (years)CFA positive (%)Nyanjati760.66.97 (9.2)1730.76.870.0Nyamisati810.77.615 (18.5)1321.87.860.0Mchukwi790.97.512 (15.1)1301.27.680.0Bungu970.77.816 (16.5)1221.17.660.0Nyambili800.97.49 (11.3)1021.67.730.0Total4130.87.459 (14.3)6591.17.510.0[^1][^2]

In 2015, a total of 659 standard one children aged between 6 and 9 years (mean 7.5 years) were tested for *W. bancrofti* CFA in the five selected schools. Of the tested pupils, 346 (52.5%) were male and 313 (47.5%) were female. None of the pupils examined tested positive for *W. bancrofti* CFA ([Table 1](#tbl0005){ref-type="table"}). With respect to participation in MDA, 54.3% (*n* = 358) of the tested pupils reported that they had always swallowed the drugs when given out in each MDA round. The same proportion of pupils (54.3%) reported having swallowed the drugs during the last MDA that took place in October 2014 (12th round). Statistical analysis revealed that participation in the MDA was not significantly different with regard to sex (Chi-square test, *p* = 0.012) or age (Chi-square test, *p* = 0.15) of the pupils.

Reported and surveyed community treatment coverage {#sec0050}
--------------------------------------------------

MDA treatment coverage was assessed using two methods: the official NLFEP-reported coverage from the district NTD office and interviews conducted in the study villages ([Table 2](#tbl0010){ref-type="table"}, [Table 3](#tbl0015){ref-type="table"}). The NLFEP reported annual treatment coverage for Rufiji District ranging from 54.3% to 94.0% during the years 2002--2014. MDA was not administered in 2005 ([Table 2](#tbl0010){ref-type="table"}).Table 2Official NLFEP treatment coverage for Rufiji District where the five study schools are located.Table 2YearTarget populationNo. treated% treated2014226 939154 31968.72013217 274168 93077.72012203 835124 74761.22011170 606150 133882010166 682113 67768.22009162 848130 279802008159 103115 35072.52007155 443116 583752006151 86885 046562005------2004144 962136 267942003141 628123 216872002138 37075 13554.3[^3][^4]Table 3Drug uptake and ownership and use of insecticide-treated nets in relation to population characteristics among interviewed adults in Rufiji District, southeastern Tanzania.Table 32012 survey2015 surveyPopulation characteristicsNo. of people (% per category)Drug uptake (%)*p*-ValuePopulation characteristicsNo. of people (% per category)Drug uptake (%)*p*-ValueGender (*n* = 246)Gender (*n* = 868) Female159 (64.6)72 (45.2)0.007 Female471 (54.2)277 (58.2)0.254 Male87 (35.4)55 (63.2) Male397 (45.8)218 (54.9Age group (years) (*n* = 246)Age groups (years) (*n* = 868) 15--2994 (38.2)43 (45.7)0.001 15--29345 (39.7)182 (52.7)0.000 30--49115 (46.7)65 (56.5) 30--49357 (41.1)228 (63.7) ≥5037 (15.1)19 (51.3) ≥50166 (19.1)85 (73.2)Education (*n* = 246)Education (*n* = 868) Not gone to school40 (25.8)16 (40)0.001 No education224 (25.8)119 (53.6)0.001 Primary education88 (35.8)45 (51.1) Primary education487 (56.2)286 (58.7) Secondary education86 (35.0)44 (51.1) Secondary education139 (16.0)80 (57.6) Post-secondary education32 (13.0)20 (62.5) Post-secondary education18 (2.1)10 (55.6)Stay in the village (*n* = 246)Stay in the village (*n* = 868) Since birth116 (47.2)64 (55.2)0.7 Since birth413 (47.6)206 (49.9)0.004 Less than 1 year70 (28.5)33 (47.1) Less than 1 year48 (5.5)23 (47.9) 1--5 years39 (15.9)20 (51.3) 1--5 years103 (11.9)69 (66.9) More than 5 years21 (8.5)10 (41.7) More than 5 years279 (32.2)172 (61.3) No answer00 No answer25 (2.8)25 (100)Participated in the last MDA (*n* = 246)Participated in the last MDA (*n* = 868) Swallowed drugs127 (51.6)0 Swallowed drugs495 (57.0)0.000 Did not swallow drugs119 (48.4) Did not swallow drugs341 (39.3) Don't remember32 (3.6)Possess LLINs (*n* = 246)Possess LLINs (*n* = 868) Own LLINs156 (63.4)79 (50.6)0.684 Own LLINs803 (92.5)440 (54.7)0.000 Do not possess LLINs90 (36.6)48 (53.5) Do not possess LLINs65 (7.5)55 (84.6)Used LLINs last night (*n* = 246)Used LLINs last night (*n* = 764) Used146 (59.2)74 (50.7)0.721 Used576 (75.4)321 (5.8)0.004 Not used100 (40.7)53 (53) Not used188 (24.6)153 (81.4)[^5]

Surveyed treatment coverage was assessed by interviews conducted in 2012 and 2015. Demographic information of the respondents in both surveys is presented in [Table 3](#tbl0015){ref-type="table"}. In the 2012 survey, in which 246 heads of households were interviewed, it was found that the drug uptake in the 2011 MDA campaign was 51.6%. Moreover, participation in more than four previous rounds of MDA was reported to be 33.0%. Analysis by gender, age group, and education level revealed that individuals above 30 years of age were significantly more compliant with the MDA ([Table 3](#tbl0015){ref-type="table"}).

In the 2015 survey, a total of 868 heads of households were interviewed, of whom 54.2% were female and 45.8% were male. Of these respondents, more than half (57.0%) reported having swallowed the drugs in the 2014 MDA campaign. Only 22.1% reported having swallowed the drugs more than four times in the previous MDA rounds. Analysis by age group revealed that individuals above 30 years of age were significantly more compliant with the MDA (Chi-square test, *p* = 0.000; [Table 3](#tbl0015){ref-type="table"}). Being absent during drug distribution was cited as the major reason for not participating in MDA rounds, as presented in [Figure 1](#fig0005){ref-type="fig"}.Figure 1Reasons given for not taking drugs in the last round of mass drug administration (MDA); results are expressed as the percentage of the respondents who did not take drugs in the last MDA in 2015 (*n* = 370).Figure 1

Community utilization of LLINs {#sec0055}
------------------------------

Heads of households were interviewed on their possession and utilization of LLINs, and if allowed, the interviewer verified the availability of the LLINs. In the 2012 survey, 63.4% of the 246 heads of households interviewed possessed LLINs and 59.2% reported having slept under LLINs the previous night ([Table 3](#tbl0015){ref-type="table"}). In contrast, in the 2015 survey of 868 heads of households, possession was reported to be 92.5% and sleeping under LLINs the previous night was reported to be 75.4% ([Table 3](#tbl0015){ref-type="table"}).

Discussion {#sec0060}
==========

Since the launch of the GPELF in 2000, countries in endemic areas have initiated LF transmission control activities based on MDA, and progress towards the elimination goal has been reported elsewhere ([@bib0070]). Moreover, studies have indicated that ITNs lower the prevalence and transmission of LF ([@bib0065], [@bib0005], [@bib0060]). As a reduction in transmission will lead to a simultaneous decrease in acquisition of infection, it has been suggested that young children be screened to assess the effectiveness of transmission control interventions during LF elimination programmes ([@bib0135]). The current study monitored the effect of MDA on LF infection in school children living in the endemic district of Rufiji in southeastern Tanzania. Compliance with MDA and the utilization of ITNs were assessed in the study areas.

Before the onset of LF control activities in Rufiji District, the baseline *W. bancrofti* CFA in adults was reported to range from 49% to 64% (MoHSW 2012, unpublished). In the current study, surveys conducted in 2012 and 2015, which coincided with the 9th and 12th rounds of MDA, reported *W. bancrofti* CFA prevalence of 14.3% and 0.0%, respectively. The findings of the 2015 survey indicate a remarkable reduction in *W. bancrofti* CFA prevalence in young children after 12 rounds of MDA. Based on other studies that have reported a reduction in CFA as a result of MDA ([@bib0095], [@bib0105]), the findings suggest a decrease in acquisition of new infections by young school children as a result of MDA.

Treatment coverage and community compliance are important factors for successful LF elimination through the MDA strategy. It has been shown that in areas with high pre-MDA levels of infection, maintaining high drug intake during MDA is crucial in order to reach the elimination goal within a reasonable time frame ([@bib0050], [@bib0055]). In the current study, the overall surveyed drug uptake for 2011 (surveyed in 2012) was 51.6% and for 2014 (surveyed in 2015) was 57.4%. The official reported treatment coverage for the respective years was 88.0% and 68.7%. This suggests that reported MDA coverage was relatively higher than surveyed coverage, as has also been reported elsewhere ([@bib0100]). The surveyed percentages of drug uptake in the current study were lower than the minimum of 65% required to attain the interruption of LF transmission, and this observation has been documented in other places implementing the programme ([@bib0140]). Lower than optimal drug uptake is a challenge to the success of MDA campaigns in some areas of Tanzania ([@bib0030], [@bib0105]). In the current study, being absent during drug distribution was cited as the major reason for not taking the drugs. This was also noted in studies conducted previously in other parts of Tanzania ([@bib0030], [@bib0105]).

Despite the lower than optimal treatment coverage observed in this study, the survey for CFA in school pupils in 2015 indicated a marked reduction in transmission when compared to 2012 infection levels. These contrasting findings may be due to an increase in ownership and utilization of ITNs, found to be 92.5% and 75.4%, respectively, in the 2015 survey. Of particular relevance, it has been shown that the use ITNs for malaria control has had an effect in reducing filarial rates ([@bib0065], [@bib0005], [@bib0025]). Moreover, a study conducted in the Coast Region of Kenya reported a sustained reduction in LF transmission despite missed rounds of MDA, due to the impact of the ITN intervention ([@bib0060]). It is thus suggested that the lower drug uptake in this study was complemented by high ITN coverage, which sustained the CFA reductions observed. Although this study recorded a marked reduction in acquisition of new infection by young school pupils in the study areas, a formal transmission assessment survey (TAS) is recommended to establish whether the transmission of LF has been interrupted in Rufiji District.

In conclusion, the findings of this study suggest that 12 rounds of MDA complemented with vector control through the use of ITNs resulted in a marked reduction in *W. bancrofti* CFA in young school children. It is recommended that a formal TAS is conducted to establish whether the transmission of LF has been interrupted in Rufiji District.
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[^1]: CFA, circulating filarial antigen.

[^2]: Ratio of males to females.

[^3]: NLFEP, Tanzanian National Lymphatic Filariasis Elimination Programme.

[^4]: Source: Tanzania Neglected Tropical Disease Control Programme.

[^5]: MDA, mass drug administration; LLINs, long-lasting insecticide-treated nets.
